Circle Pharma Raises $90M in Series D

Circle Pharma has successfully raised $90M in a Series D led by The Column Group.

Company Overview

Circle Pharma is a HealthTech company headquartered in South San Francisco, CA, founded in 2015 with 80+ employees.

Biotech developing cell-permeable macrocycles for treating previously undruggable targets

Fundraising Details

• Amount Raised: $90M
• Round Type: Series D
• Date: 2025-08-21
• Investors: The Column Group

About Circle Pharma

Biotech developing cell-permeable macrocycles for treating previously undruggable targets The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: South San Francisco, CA
• Founded: 2015
• Team Size: 80+
• Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Circle Pharma's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Circle Pharma's successful fundraising reflects the strong fundamentals and growth potential in this space.

Looking Ahead

With this new capital, Circle Pharma is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-08-21. For more information about Circle Pharma, visit their headquarters at South San Francisco, CA.